{"organizations": [], "uuid": "ceb4e84a659787dc1d77cdb263ec0a1d85aaf618", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/sorrento-thera-fda/fda-approves-sorrentos-painkiller-patch-idUSL4N1QI6I8", "country": "US", "domain_rank": 408, "title": "FDA approves Sorrento's painkiller patch", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-28T21:16:00.000+02:00", "replies_count": 0, "uuid": "ceb4e84a659787dc1d77cdb263ec0a1d85aaf618"}, "author": "", "url": "https://www.reuters.com/article/sorrento-thera-fda/fda-approves-sorrentos-painkiller-patch-idUSL4N1QI6I8", "ord_in_thread": 0, "title": "FDA approves Sorrento's painkiller patch", "locations": [], "entities": {"persons": [{"name": "sorrento", "sentiment": "negative"}, {"name": "arun koyyur", "sentiment": "none"}, {"name": "tamara mathias", "sentiment": "none"}], "locations": [{"name": "bengaluru", "sentiment": "none"}], "organizations": [{"name": "reuter", "sentiment": "negative"}, {"name": "fda", "sentiment": "negative"}, {"name": "reuters", "sentiment": "none"}, {"name": "u.s. food and drug administration", "sentiment": "none"}, {"name": "sorrento therapeutics inc", "sentiment": "none"}, {"name": "scilex pharmaceuticals inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "February 28, 2018 / 7:16 PM / Updated 27 minutes ago FDA approves Sorrento's painkiller patch Reuters Staff 1 Min Read Feb 28 (Reuters) - The U.S. Food And Drug Administration on Wednesday approved Sorrento Therapeutics Incâ€™s ZTlido, a stick-on patch to treat nerve pain due to shingles. Sorrento, which acquired Ztlido when it bought a majority stake in privately-owned SCILEX Pharmaceuticals Inc in November 2016, said it plans to launch the drug later this year. The FDA had previously rejected the treatment in 2016. Reporting by Tamara Mathias in Bengaluru; Editing by Arun Koyyur", "external_links": [], "published": "2018-02-28T21:16:00.000+02:00", "crawled": "2018-02-28T21:48:05.014+02:00", "highlightTitle": ""}